Post Profile






Inhibiting 1 protein restores treatment benefit in resistant breast cancer

(Georgetown University Medical Center) A team of researchers has found, in animal models of human breast cancer, that inhibiting a single protein restores sensitivity to tamoxifen, a commonly used drug for treatment of some breast cancers.
read more

share

Related Posts


Biomarker Of Tamoxifen Resistance In Breast Cancer Identified

Health : Medical News Today

New research led by the University of Manchester in the UK has found a biomarker or molecular "flag" in women with breast cancer who do not repond, or who have become resistant, to treatment with the hormone drug tamoxifen. The rese...

Scientists Identify Protein Involved in Restoring Effectiveness of Common Treatment for Breast Cancer

Health : Newswise Medical News

Breast cancer is the most frequently diagnosed cancer among women, with estrogen-receptor-positive (ER+) being the most common type. Drugs used to treat this cancer, such as tamoxifen and Faslodex, block the hormone estrogen recepto...

Tamoxifen Resistance Explained In Some Breast Cancers

Health : Medical News Today

Using human breast cancer cells and the protein that causes fireflies to glow, a Johns Hopkins team has shed light on why some breast cancer cells become resistant to the anticancer effects of the drug tamoxifen. The key is a discov...

Culprit found in breast cancer resistance to tamoxifen

Health : EurekAlert: Health

(University of Minnesota) Researchers have discovered that a protein found naturally in cells that provides some protection from viruses is responsible for creating mutations that drive resistance to tamoxifen treatment in breast ca...

Inhibiting Production of One Protein Restores Treatment Benefit in Resistant Breast Cancer

Health : Newswise Medical News

In animal models of human breast cancer, inhibiting a single protein restores sensitivity to tamoxifen, a commonly used drug for treatment of some breast cancers.

Comments


Copyright © 2016 Regator, LLC